Sanofi's diabetes drug Lyxumia approved in Europe
PARIS (Reuters) - Sanofi said on Monday regulators had approved Lyxumia, an injectable diabetes treatment, for sale in Europe. Also known by its generic name lixisenatide, the drug is taken once a day in conjunction with other drugs or insulin by patients who are otherwise not able to control their blood sugar levels. The drug is one of the new products the French drug maker is betting on to restore growth after losing several blockbusters to generic competition. ...
Source: news.yahoo.com
No comments:
Post a Comment